[ANTIHYPERTENSIVE PROPERTIES OF A MONOAMINE OXIDASE INHIBITOR (DL-SERINE-N2-ISOPROPYLHYDRAZIDE: RO 4-1038). CLINICAL RESULTS AND EFFECT ON RENAL FUNCTION].
D000959:Antihypertensive Agents; D001795:Blood Pressure Determination; D056486:Chemical and Drug Induced Liver Injury; D002752:Chlorthalidone; D003928:Diabetic Nephropathies; D004358:Drug Therapy; D004562:Electrocardiography; D006145:Guanethidine; D006505:Hepatitis; D006973:Hypertension; D006977:Hypertension, Renal; D007668:Kidney; D007677:Kidney Function Tests; D008996:Monoamine Oxidase Inhibitors; D009318:Natriuresis; D011704:Pyelonephritis; D012694:Serine / Q000031:analogs & derivatives; D014116:Toxicology; D014882:Water-Electrolyte Balance
D000959:Antihypertensive Agents; D008996:Monoamine Oxidase Inhibitors; C017713:serine isopropylhydrazide; D012694:Serine; D002752:Chlorthalidone; D006145:Guanethidine
BLOOD PRESSURE DETERMINATION; CHLORTHALIDONE; DIABETIC NEPHROPATHIES; DRUG THERAPY; ELECTROCARDIOGRAPHY; GUANETHIDINE; HEPATITIS, TOXIC; HYPERTENSION; HYPERTENSION, RENAL; KIDNEY FUNCTION TESTS; MONOAMINE OXIDASE INHIBITORS; NATRIURESIS; PYELONEPHRITIS; TOXICOLOGIC REPORT; WATER-ELECTROLYTE BALANCE
DIE ANTIHYPERTENSIVEN EIGENSCHAFTEN EINES MONOAMINOXYDASEHEMMERS (DL-SERIN-N2-ISOPROPYLHYDRAZID: RO 4-1038). KLINISCHE ERGEBNISSE UND WIRKUNG AUF DIE NIERENFUNKTION.